9 results
8-K
EX-10.1
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
in accordance with generally accepted accounting principles.
(t) Cybersecurity. The Company’s and its subsidiaries’ information technology assets
8-K
EX-1.1
LXRX
Lexicon Pharmaceuticals Inc
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
or performance of this Agreement by the Company or the sale and delivery by the Company of the Shares.
(ss) Cybersecurity. The Company’s and its subsidiaries
8-K
EX-10.1
juh0i
11 Dec 20
Lexicon Announces Offering of Common Stock
5:28pm
- Prev
- 1
- Next